WASHINGTON — For the first time, DoD is partnering with an outside company to build a facility to manufacture countermeasures to fight bioterrorism and other medical threats.
By Sandra Basu WASHINGTON — Lawmakers expressed alarm at a government report that vendor representatives were involved directly in the application of skin grafts at a VA medical center and demanded more oversight of the use, tracking and procurement of… Read More
By Annette M. Boyle PALO ALTO, CA — Medication is only effective if taken, yet how to make sure patients maintain adherence with anticoagulants and many other long-term medications for chronic diseases poses one of the greatest dilemmas for healthcare… Read More
SAN DIEGO — The Food and Drug Administration has approved a new opioid analgesic but not without controversy. In approving Zohydro ER (hydrocodone bitartrate extended-release capsules), the FDA went against an 11-2 recommendation by a panel of outside experts to… Read More
SUNNYVALE, CA — For the first time, the Food and Drug Administration is allowing marketing of a device to relieve pain caused by migraine headaches that are preceded by an aura. The device, the Cerena Transcranial Magnetic Stimulator (TMS), is… Read More
WASHINGTON — A new sodium-glucose co-transporter 2 (SGLT2) inhibitor has been approved to treat type 2 diabetes. The Food and Drug Administration approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults. Farxiga is marketed… Read More
HOUSTON — About 40% of veterans with anxiety disorders receive a “placeholder” diagnosis that often remains with them indefinitely — and dramatically reduces the likelihood they ever will receive appropriate care, according to a new study.
INDIANAPOLIS — From press reports, it might seem that everyone is talking about opioid analgesics. The question that VA researchers set out to answer, however, is how prescribers were discussing use of the pain relievers with their patients. A pilot… Read More
ST. LOUIS, MO — The chronic use of opioid analgesics is linked to an increase in the risk of developing major depression, according to a review of veterans’ medical records. The study, led by Saint Louis University researchers, was published… Read More
SAN FRANCISCO — Researchers now are able to predict which wounded servicemembers are likely to develop persistent, chronic pain after amputation based on variants in their individual DNA sequence. The report on the medical advancement, led by researchers from Duke… Read More